Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Paul Besseling"'
Autor:
Samuel J. Wattrus, Miook Cho, Austin Valido, Amy J. Wagers, Kathleen A. Messemer, Paul Besseling, Richard T. Lee, Ryan G. Walker, Melanie J. Mills, Jill M. Goldstein, Kyu Ha Lee, Jordan P. Lewandowski
Publikováno v:
Scientific Reports, Vol 9, Iss 1, Pp 1-19 (2019)
Scientific Reports
Scientific Reports
Recent advances in CRISPR/Cas gene editing technology have significantly expanded the possibilities and accelerated the pace of creating genetically engineered animal models. However, CRISPR/Cas-based strategies designed to precisely edit the genome
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cf23623c74443ab125114c1e26986909
http://link.springer.com/article/10.1038/s41598-019-54766-y
http://link.springer.com/article/10.1038/s41598-019-54766-y
Publikováno v:
Biology of Blood and Marrow Transplantation, 22(2), 195. Elsevier Inc.
Allogeneic (allo) hematopoietic cell transplantation (HCT) has evolved into a potent curative treatment option for a variety of malignant and nonmalignant diseases. The occurrence of complications and mortality after allo-HCT is, however, still high
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fb45c237a94441c81fa15b1d107b5778
https://doi.org/10.1016/j.bbmt.2015.08.028
https://doi.org/10.1016/j.bbmt.2015.08.028
Autor:
Paul Besseling, Maarten van 't Riet
Should one calculate user benefits from changes in door-to-door journeys or from changes in the use of separate links of the network? Quite often, the second approach is deemed wrong, as consumers are supposed to demand journeys, not parts of journey
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______645::6dbe980b843270cd7b7af0afcae47d2a
http://www.cpb.nl/sites/default/files/publicaties/download/welfare-analysis-transport-networks.pdf
http://www.cpb.nl/sites/default/files/publicaties/download/welfare-analysis-transport-networks.pdf
Publikováno v:
Tissue Engineering Part A: Tissue Engineering; 2022 Supplement, Vol. 28 Issue 1, pS-1-S-654, 654p
Publikováno v:
De Economist (0013-063X). Sep2002, Vol. 150 Issue 3, p323-324. 2p.
Autor:
Don, Henk1 don@ese.eur.nl
Publikováno v:
De Economist (0013-063X). Jun2009, Vol. 157 Issue 2, p251-264. 14p. 1 Graph.
Autor:
Goldstein, Jill M.1,2,3, Valido, Austin1, Lewandowski, Jordan P.1,2, Walker, Ryan G.1,2, Mills, Melanie J.1,2, Messemer, Kathleen A.1,2,3, Besseling, Paul1,2, Lee, Kyu Ha4, Wattrus, Samuel J.1,2, Cho, Miook1,2,3, Lee, Richard T.1,2, Wagers, Amy J.1,2,3,5 amy_wagers@harvard.edu
Publikováno v:
Scientific Reports. 12/9/2019, Vol. 9 Issue 1, pN.PAG-N.PAG. 1p.
Publikováno v:
Financing Retirement in the European Union; 2002, p1-27, 27p, 5 Charts
Autor:
Bovenberg, A.
Publikováno v:
International Tax & Public Finance; Nov2003, Vol. 10 Issue 6, p713-734, 22p
Het plan van het kabinet om de AWBZ, vaak langdurige zorg voor mensen met een aandoening of beperking, risicodragend te laten uitvoeren door zorgverzekeraars gaat extra geld kosten. Dat stellen CPB-economen Paul Besseling, Wouter Elsenburg en Casper
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::b156c4567a99422354f45787f2be8b79
http://www.mejudice.nl/artikelen/detail/risicodragende-uitvoering-awbz-door-zorgverzekeraars-verhoogt-de-kosten
http://www.mejudice.nl/artikelen/detail/risicodragende-uitvoering-awbz-door-zorgverzekeraars-verhoogt-de-kosten